Combination treatment for lung cancer spread to the lining of the brain
Part of Cancer clinical trials.
This trial tests a new combination of two drugs for people with a specific type of lung cancer that has spread to the lining of the brain and spinal cord. The treatment aims to target the cancer cells and may help improve symptoms and survival.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a lung cancer type called EGFR-mutated lung adenocarcinoma.
- The cancer has spread to the lining of the brain and spinal cord (leptomeningeal metastasis).
- You are at least 18 years old.
- You are expected to live at least 3 more months.
- Your major organs (kidneys, liver, heart, and bone marrow) are working well enough.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of proton radiation to the brain and spine plus chemotherapy given directly into the fluid around the brain and spinal cord. It is for people with a specific type of lung cancer (EGFR-mutant non-small cell lung cancer) that has spread to the lining of the brain and has continued to grow despite taking a third-generation TKI medicine like osimertinib.
This trial tests a treatment given directly into the fluid around the brain and spinal cord (intrathecal injection) using two drugs—pemetrexed and bevacizumab—for people with non-small cell lung cancer that has spread to that area (leptomeningeal metastases). It may be an option if your current treatment is no longer working.
This trial tests a combination of two drugs, pemetrexed and nivolumab, given directly into the fluid around the brain and spinal cord. It is for people with a specific type of lung cancer (non-squamous non-small cell) that has spread to the lining of the brain and has not responded to other treatments.
This trial tests a stronger dose of an EGFR-targeted drug combined with bevacizumab and chemotherapy into the spinal fluid for patients with non-small cell lung cancer that has spread to the lining of the brain and is no longer responding to standard treatment.
This trial tests a combination of three drugs (pemetrexed given into the spinal fluid, high-dose furmonertinib by mouth, and bevacizumab) for people with a specific type of lung cancer that has spread to the lining of the brain or spinal cord (leptomeningeal metastases). The goal is to see if this treatment can help control the cancer in this hard-to-treat area.
This trial tests a drug called pemetrexed, given directly into the fluid around the spinal cord (intrathecal), for people with lung cancer that has spread to the brain and spinal cord lining and is no longer controlled by the targeted therapy osimertinib.
Hear when a new Leptomeningeal Metastasis From Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.